6-chloro-4-hydrazino-quinoline | 68500-31-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 6-chloro-4-hydrazino-quinoline
• 英文别名: 6-Chlor-chinol-4-ylhydrazin；6-Chloro-4-hydrazinoquinoline；(6-chloroquinolin-4-yl)hydrazine
• CAS: 68500-31-2
• 化学式: C₉H₈ClN₃
• 分子量: 193.636
• InChiKey: ZFGQCTXYMNTVEA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  50.9
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  6-chloro-4-hydrazino-quinoline 在 三乙胺 、 肼 作用下， 以 四氢呋喃 、 二乙二醇 为溶剂， 反应 9.0h， 生成 N-(4-chloro-2-{1-[(4-methylphenyl)sulfonyl]-1H-pyrazol-3-yl}phenyl)-4-methylbenzenesulfonamide
  参考文献：
  名称：

  Synthesis andin vitroEvaluation of New Benzenesulfonamides as Antileishmanial Agents

  摘要：

  This paper describes the synthesis and the antileishmanial activity of new pyrazolyl benzenesulfonamide derivatives. These were elucidated by spectrometric methods. Some compounds showed a significant in vitro activity against Leishmania amazonensis, highlighting the derivative 1e. These pyrazolyl benzenesulfonamide derivatives did not show any toxicity in murine macrophage.

  DOI：

  10.5935/0103-5053.20140062
• 作为产物：
  描述：

  6-氯-4-羟基喹啉 在 肼 、 三氯氧磷 作用下， 以 二乙二醇 为溶剂， 反应 25.0h， 生成 6-chloro-4-hydrazino-quinoline
  参考文献：
  名称：

  Synthesis andin vitroEvaluation of New Benzenesulfonamides as Antileishmanial Agents

  摘要：

  This paper describes the synthesis and the antileishmanial activity of new pyrazolyl benzenesulfonamide derivatives. These were elucidated by spectrometric methods. Some compounds showed a significant in vitro activity against Leishmania amazonensis, highlighting the derivative 1e. These pyrazolyl benzenesulfonamide derivatives did not show any toxicity in murine macrophage.

  DOI：

  10.5935/0103-5053.20140062

文献信息

• [EN] PYRIDAZINONE DERIVATIVES<br/>[FR] DÉRIVÉS DE PYRIDAZINONE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2010063610A1

  公开（公告）日：2010-06-10

  The present invention is concerned with novel pyridazinone derivatives of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as medicaments.

  本发明涉及一种新颖的吡啶并嗪酮衍生物，其化学式为（I），其中R1、R2、R3和R4如描述和权利要求中所定义，并且其生理上可接受的盐和酯。这些化合物抑制PDE10A，可用作药物。
• HETEROARYL SUBSTITUTED PYRIDAZINONE DERIVATIVES
  申请人：Alberati Daniela

  公开号：US20100216793A1

  公开（公告）日：2010-08-26

  The present invention is concerned with novel pyridazinone derivatives of formula (I) wherein R 1 , R 2 , R 3 and R 4 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as pharmaceuticals.

  本发明涉及具有如下式（I）的新型吡啶并嗪酮衍生物，其中R1、R2、R3和R4如描述和索赔中所定义，并且其生理上可接受的盐和酯。这些化合物抑制PDE10A并可用作药物。
• Design, Synthesis and Anti-tuberculosis Activity of Hydrazones and N-acylhydrazones Containing Vitamin B6 and Different Heteroaromatic Nucleus
  作者：Thais Cristina Mendonça Nogueira、Lucas dos Santos Cruz、Maria Cristina Lourenço、Marcus Vinicius Nora de Souza

  DOI：10.2174/1570180815666180627122055

  日期：2019.6.27

  Background: The term vitamin B6 refers to a set of six compounds, pyridoxine, pyridoxal ,and pyridoxamine and their phosphorylated forms, among which pyridoxal 5´-phosphate (PLP) is the most important and active form acting as a critical cofactor. These compounds are very useful in medicinal chemistry because of their structure and functionalities and are also used in bioinorganic chemistry as ligands

  背景：术语维生素 B6 是指一组六种化合物，即吡哆醇、吡哆醛和吡哆胺及其磷酸化形式，其中 5´-磷酸吡哆醛 (PLP) 是最重要和最活跃的形式，作为关键辅因子。由于这些化合物的结构和功能，这些化合物在药物化学中非常有用，并且在生物无机化学中也用作与金属络合的配体。方法：在这项研究中，从商业盐酸吡哆醛和适当的芳香族或杂芳香族肼或 N-酰基肼合成了一系列含有维生素 B6 的腙 1a-g 和 N-酰基腙2a-f。所有合成的化合物都已完全表征并针对结核分枝杆菌进行了测试。结果：在N-酰基腙衍生物2a-f中，2d（对吡啶取代的腙；MIC = 10.90 μM）表现出最好的活性。邻吡啶衍生物 2b 表现出中等活性 (MIC = 87.32 μM)，而间吡啶衍生物 2c 无活性。在腙系列 1a-g 的情况下，7-氯喹喔啉衍生物 1f (MIC = 72.72 μM) 显示出最好的结果，表明自由基部分中的
• Pyridazinones
  申请人：Hoffmann-La Roche Inc.

  公开号：US08178538B2

  公开（公告）日：2012-05-15

  The present invention is concerned with novel pyridazinones of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used for the treatment of CNS disorders.

  本发明涉及式（I）的新型吡啶二酮，其中R1、R2、R3和R4在说明书和权利要求中定义，以及其生理上可接受的盐和酯。这些化合物抑制PDE10A，可用于治疗中枢神经系统疾病。
• PYRIDAZINONES
  申请人：Alberati Daniela

  公开号：US20100152193A1

  公开（公告）日：2010-06-17

  The present invention is concerned with novel pyridazinones of formula (I) wherein R 1 , R 2 , R 3 and R 4 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used for the treatment of CNS disorders.

  本发明涉及式（I）的新型吡啶二酮化合物，其中R1、R2、R3和R4如所述和所述权利要求中定义，以及其生理上可接受的盐和酯。这些化合物抑制PDE10A，并可用于治疗中枢神经系统疾病。